B. Saez-Gimenez (Barcelona, Spain), M. Hellemons (Rotterdam, Netherlands)
This session is built from abstracts published on the ERS Congress platform from 23 August, in an e-poster pdf format with a 3-minute audio narration. Participants and chairs of the session are invited to access all e-posters from 23 August to 4 September prior to the 1-hour live, online discussion scheduled from September 5-7. Please note that during live discussion there will be NO e-poster/abstract presentations, only discussion.
Lung transplantation for COVID-19 induced ARDS: a single-center experience
C. Lang (Vienna, Austria), P. Boehm (Vienna, Austria), P. Jaksch (Vienna, Austria), G. Muraközy (Vienna, Austria), A. Benazzo (Vienna, Austria), S. Schwarz (Vienna, Austria), T. Schweiger (Vienna, Austria), P. Berend (Vienna, Austria), G. Lang (Vienna, Austria), J. Matilla (Vienna, Austria), M. Hoda (Vienna, Austria), B. Moser (Vienna, Austria), S. Taghavi (Vienna, Austria), W. Klepetko (Vienna, Austria), K. Hoetzenecker (Vienna, Austria)
|   |
Short and mid-term outcomes of lung transplant recipients with COVID-19
S. Happaerts (Leuven, Belgium), N. Lorent (Leuven, Belgium), J. Yserbyt (Leuven, Belgium), L. Dupont (Leuven, Belgium), C. Dooms (Leuven, Belgium), P. Van Bleyenbergh (Leuven, Belgium), B. Vanaudenaerde (Leuven, Belgium), S. Verleden (Leuven, Belgium), L. Ceulemans (Leuven, Belgium), D. Van Raemdonck (Leuven, Belgium), G. Verleden (Leuven, Belgium), R. Vos (Leuven, Belgium), L. Godinas (Leuven, Belgium)
| |
Covid 19 in a lung transplant population
J. Kleinerová (Dublin, Ireland), A. Blum (Dublin, Ireland), P. Ging (Dublin, Ireland), M. Murray (Dublin, Ireland), P. O’Gorman (Dublin, Ireland), J. Egan (Dublin, Ireland)
| |
Cryptococcus infections in cardiothoracic transplant recipients – a variable journey
R. Sehajpal (London, United Kingdom), K. Dave (London, United Kingdom), D. Armstrong-James (London, United Kingdom), M. Carby (London, United Kingdom), O. Dar (London, United Kingdom), A. Reed (London, United Kingdom), V. Gerovasili (London, United Kingdom)
| |
Surveillance bronchoscopy in cystic fibrosis transplanted patients is safe and effective.
M. Damin (Padova (PD), Italy), D. Biondini (Padova (PD), Italy), M. Tine (Padova (PD), Italy), M. Rizzo (Padova (PD), Italy), G. Andreotti (Padova (PD), Italy), S. Petrarulo (Padova (PD), Italy), E. Bazzan (Padova (PD), Italy), G. Turato (Padova (PD), Italy), F. Rea (Padova (PD), Italy), F. Calabrese (Padova (PD), Italy), E. Balestro (Padova (PD), Italy), M. Cosio (Montreal, Canada), M. Saetta (Padova (PD), Italy)
| |
Single centre lung transplant experience of customised biodegradable stents in the early post-lung transplant period.
K. Dave (LONDON, United Kingdom), F. Imam (LONDON, United Kingdom), N. Mayer (LONDON, United Kingdom), N. Asadi (LONDON, United Kingdom), M. Carby (LONDON, United Kingdom), A. Reed (LONDON, United Kingdom), V. Gerovasili (LONDON, United Kingdom)
| |
Airway oscillometry after single lung transplantation is characterised by abnormal respiratory reactance
J. Sim (Sydney, Australia), D. Darley (Sydney, Australia), K. Nilsen (Melbourne, Australia), R. Shirol (Sydney, Australia), B. Borg (Melbourne, Australia), J. Vazirani (Melbourne, Australia), B. Levvey (Melbourne, Australia), G. Snell (Melbourne, Australia), M. Plit (Sydney, Australia), K. Tonga (Sydney, Australia)
| |
Prognostic significance of amino-terminal pro-brain natriuretic peptide testing among waitlisted lung transplant candidates
s. izhakian ( Petach Tikva, Israel), A. Frajman ( Petach Tikva, Israel), L. Freidkin ( Petach Tikva, Israel), M. Kramer ( Petach Tikva, Israel)
| |
Late Breaking Abstract - Prognostic impact of decreased erector spinae muscle radiographic density after lung transplantation
Y. Oshima (Kyoto, Japan), S. Sato (Kyoto, Japan), T. Chen-Yoshikawa (Nagoya, Japan), D. Nakajima (Kyoto, Japan), Y. Yoshioka (Kyoto, Japan), R. Hamada (Kyoto, Japan), A. Otagaki (Kyoto, Japan), M. Nankaku (Kyoto, Japan), H. Date (Kyoto, Japan), S. Matsuda (Kyoto, Japan)
| |